Read More Pharma Industry News FDA accepts Airway’s IND for AT-100 for bronchopulmonary dysplasia treatment in preterm infants Bronchopulmonary dysplasia treatment : Airway Therapeutics said that the US Food and Drug Administration (FDA) has accepted its… bySrinathMarch 27, 2021
